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ABSTRACT
The binding of the chemotactic peptide N-formylnorleucylleucylphenylalanine
(FNLLP) to its receptor on rabbit polymorphonuclear leukocytes (PMNs) modu-
lates the number of available peptide receptors . Incubation with FNLLP decreases
subsequent binding capacity, a phenomenon that has been termed receptor down
regulation . Down regulation of the chemotactic peptide receptor is concentration
dependent in both the rate and extent of receptor loss . The dose response parallels
that of FNLLP binding to the receptor . The time-course _ is rapid ; even at
concentrations ofFNLLP as low as 3 x 10-9 M, the new equilibrium concentration
of receptors is reached within 15 min . Down regulation is temperature dependent,
but does occur even at 4°C .
Concomitant with down regulation, some of the peptide becomes irreversibly
cell associated . At 4°C, there is a small accumulation of nondissociable peptide
that rapidly reaches a plateau . At higher temperatures, accumulation of nondis-
sociable peptide continues after the receptor number has reached equilibrium, and
the amount accumulated can exceed the initial number of receptors by as much
as 300%. The dose response of peptide uptake at 37 °C reflects that of binding,
suggesting that it is receptor mediated . This uptake may occur via a pinocytosis
mechanism . Although PMNs have not been considered to be pinocytic, the
addition of FNLLP causes a fourfold stimulation of the rate of pinocytosis as
measured by the uptake of [ 3H)sucrose .
Polymorphonuclear leukocytes (PMNs) are phag-
ocytic cells that are able to exhibit chemotaxis to
a variety of agents, including denatured proteins
(34), bacterial products (14), oxidized lipids (29),
cell-derived factors (27, 32), serum components,
particularly C5a (13, 25, 31), and small formylated
peptides (23, 26) . The ability of PMNs to orient
and move in chemotactic gradients provides a
system in which two key biological problems can
be studied : the sensory detection of chemical sub-
stances, and cell movement. We have used the
chemotactic peptide, N-formylnorleucylleucyl-
phenylalanine (FNLLP), to study the first step in
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the chemotactic response, namely, the interaction
ofFNLLP with its receptor.
Several studies have demonstrated the presence
ofspecific, saturable receptors for formylated pep-
tides on PMNs (1, 22, 36) . These peptides have
made it possible to study the behavior ofPMNs in
specific gradients . Characteristics of the binding
can be predicted from the behavior. The orienta-
tion ofthe cells in a chemical gradient is rapid and
readily reversible ; the rates of binding and disso-
ciation are also rapid . Cells in a gradient have
been shown to orient optimally at concentrations
close to the dissociation constant, Kd, for the bind-
703ing. In addition, it has beenshown that PMNs can
orient in this optimal range when the concentra-
tion difference across their dimensions is only-1%
(37) .
We have recently presented evidence which sug-
gests that the sensitivity ofPMNs to concentration
changes maybe increased by their ability to adapt
to theconcentration ofpeptide present (38) . PMNs
treated with chemotactic factors undergo transient
changes in morphology (38), adhesion (7, 20), and
ion fluxes (3, 18) . After -3 min the cells adapt to
this chemotactic stimulation and revert, at least
partially, to their prestimulated state . Cells
adapted to a given concentration of chemotactic
factor will respond to changes in concentration . It
has been known for many years that incubation
with chemotactic factors can result in a loss of
chemotactic responsiveness . This phenomenon has
been termed deactivation (30) . In this report, we
demonstrate that one ofthe responsesofPMNs to
the binding of FNLLP is a modulation of the
number of receptors that are subsequently availa-
ble for binding. This receptor modulation may be
onemechanism of adaptation and/or deactivation.
MATERIALS AND METHODS
Cells
Rabbit peritoneal exudate cells were collected four h after
injection of 0.1 g of shellfish glycogen (Schwartz/Mann Div.,
Becton, Dickinson& Co ., Orangeburg, N. Y .) in 250 ml of0.9%
saline. Contaminating erythrocytes were lysed by brief (60 s)
treatment with hypotonic (0.18%) saline . The cells were washed
twice with 0.9% saline and then resuspended in Hanks' balanced
salt solution (Grand Island Biological Co ., Grand Island, N.Y.)
buffered with 2.4 mg/m1 of HEYES (Sigma Chemical Co .) at a
concentration of 3.3 x 10' cells/ml . 3 ml of the cell suspension
wasadded to 60 x 15 mm petri dishes (Falcon Labware, Div.,
Becton, Dickinson & Co ., Oxnard, Calif .), and the cells were
allowed to settle for 15 min at 23°C . Dishes were checked with
an inverted microscope (Olympus Corp . of America, New Hyde
Park, N . Y.) to insure the cells had formed an even monolayer.
Binding Studies
Each dish containing 10' cells was incubated in 0.5 ml of
Hanks' solution with the appropriate concentration of tritiated
(12.5 Ci/mM) FNLLP . After incubation, this medium was aspi-
rated and the dish was washed quickly (6 s) and vigorously in
two baths of 4°C saline . The reversibility of binding was meas-
ured by varying the time of the wash in chilled saline. Cell-
associated radioactivity was measured by adding 0.5 ml of0.1 N
NaOH to each dish . The cells were scraped into this fluid with a
rubber policeman, and then each dish waswashed with 0.5 ml of
distilled water . This 1 ml of cell suspension was counted in 15 ml
ofscintillationfluid Formula 963(New England Nuclear, Boston,
Mass.) with an efficiency of -40% . In preliminary experiments,
Lowry assays were done (16) to confirm that cells were not lost
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from any ofthe dishes during the treatment . In all experiments
the dishes were monitored visually for cell loss .
Down Regulation
Cells were preincubated with unlabeled FNLLP for various
lengths of time at 37° or 4°C. At the end of the incubation, the
medium was aspirated and the cells were washed for 5 min at
4°C with chilled saline (5 x2ml washes) . The rebinding capacity
was measured by adding 0.5 ml of Hanks' solution with tritiated
FNLLP for 15 min at 4°C. At the end of this incubation, the
cells were washed quickly as outlined above. For receptor recov-
ery experiments, the cells were incubated for 20 min at 37°C and
washed for 5 min. Cells were then incubated in Hanks' solution
for various times at 37 °C before being assayed for rebinding.
Control cells were preincubated without peptide but were sub-
jected to the same washing procedure.
Pinocytosis
Fluid uptake was measured by the uptake of tritiated sucrose
(11 .2 Ci/mmol, New England Nuclear) from themedium . Cells
were incubated with 10 -fi M l'Hlsucrose in the presence or
absence of unlabeled FNLLP. At the end of the incubation, the
medium was aspirated and the cells were washed for 5 min at
4°C . Cell-associated activity was assayed as described previously .
Drugs
2-Deoxy-n-glucose (Sigma Chemical Co.) was used in binding
studies at a final concentration of 0.5 mM in Hanks' medium
containing I x 10- 'Mglucose. Cells were preincubated without
glucose for 90 min at 37°C before deoxyglucose was added.
Cycloheximide (Sigma Chemical Co.) was used at a final con-
centration of l pg/ml . Cells were preincubated with cyclohexi-
mide for 30 min at 37 °C before being tested. This wasshown to
decrease the incorporation of mixed tritiated amino acids (New
England Nuclear) by 92%. Carbobenzoxy-phenylalanyl-methio-
nine (CBZ-Phe-Met) (Vega-Fox Biochemicals Div., Newbery
Energy Corp., Tuscon, Ariz .) was used at a final concentration of
10-°M in 0.2% dimethyl sulfoxide (DMSO) (Sigma Chemical
Co.) . This concentration ofDMSO had no effect on binding or
cell viability . Preliminary experiments indicated that the K,, of
CBZ-Phe-Met binding to the peptide receptor is approximately
5 x 10-'S M.
RESULTS
Analysis of Binding
PMNs are able to respond to peptide stimulation
by forming apseudopod within 30 s . If the peptide
is removed, the pseudopods are rapidly with-
drawn . Consequently, thebindingand dissociation
of FNLLP would be expected to be rapid . The
initial rates of binding were determined at four
different concentrations of peptide. The k o can be
calculated from these initial rates according to the
equation vi = ko, (R)o (P)o, where (R)o and (P)o
are the concentrations of receptor and peptide
initially present . The number of receptors per cell
is estimated from Scatchard analysis to be 5x 104
(38) . The k, , is calculated to be 2.1 ± 0.1 x 107M` min-' (mean ± SD) . Theoffrate is calculated
from the half times of reversal after washing or
competition with excess unlabeled peptide (Fig .
1) . The amount of reversal is similar with these
two methods . The k offis -0.6 min` . However, not
all of the bound peptide is reversible. The irre-
versible binding will be discussed in a later section .
The rate of approach to equilibrium binding,
kobs, can also be used to derive the on and off rates
(24) . Thehalftime for the approach to equilibrium
is determined for various concentrations ofpeptide
by plotting the fraction of equilibrium binding as
a function of time, kobs = In 2/11/2 (Fig. 2) . The
rate of approach to equilibrium is described by the
equation :
Because the concentration of free peptide remains
essentially constant, the reaction kinetics are
pseudo first order . Thus, integration of this equa-
tion can be used to determine the kobs at different
concentrations of peptide :
A plot of kobs as a function of peptide concentra-
tion is also presented in Fig.2 . Theon rate derived
from the slope is 2 x 10'M` min' which agrees
with the value determined from the initial binding
rates. The off rate obtained from they intercept is
0.4 min-' which is also in good agreement with
that determined from the reversal of binding . The
Kd obtained from this kinetic analysis is 1 .8 x 10-s
N
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FIGURE I FNLLP binding and reversal at 4°C . (A)
Time-course of binding of 2 x 10-' MFNLLP plotted
as cell-associated cpm after a 6-s wash . (O) Reversal of
binding plotted as a function of time after the addition
of2 x l0-'MunlabeledFNLLP. (") Reversal ofbinding
as a function of time of washing in 4°C saline .
ß1E
m
FIGURE 2
￿
Left panel, saturable binding plotted semi-
logarithmically as a function of time . B, = saturable
binding at time t ; B.- = saturable binding at equilib-
rium . Saturable binding is the difference in theamount
of [3H]FNLLP bound in the absence and presence of
100-fold excess unlabeled FNLLP . (4) 8 x 10-e M
[3H]FNLLP, (") 4 x 10-BM [3H]FNLLP, (O) 2 x 10-'
M [3H]FNLLP, and (") 1 x 10-eM [3H]FNLLP . Right
panel, kobs calculated from the half time to equilibrium
binding plotted as a function of peptide concentration .
The rate constants determined from the slopeand inter-
cept are k = 2 x 10'M- ' min- ` and ktt= 0.36min-',
respectively .
M (Kd = kof/koo) . This confirms theKd obtained
previously from Scatchard analysis (38) .
The nonformylated analog ofFNLLP, HNLLP,
was shown by Aswanikumar et al . (1) not to be
chemotactic or to compete forbinding to thechem-
otactic peptide receptor . In these binding studies,
HNLLP added in concentrations of 5 x 10-' to 5
x 10-' M also did not compete for FNLLP bind-
ing.
Evidencefor Receptor Modulation
We have reported that PMNs are able to adapt
to chemotactic stimulation (38). Experiments were
designed to determine whether this adaptation
involves a change in receptor number or affinity .
Cells are incubated at 37 0C with unlabeled con-
centration, washed thoroughly, and then incu-
bated with tritiated peptide at 4'C . The binding
capacity of cells preincubated with peptide is sig-
nificantly less than that of cells preincubated with-
out peptide . To rule out the possibility that the
reduced binding was caused by competition by
released unlabeled peptide, cells were incubated
with tritiated peptide and the time-course of loss
of label was examined . Essentially all of the pep-
tide that can be removed by washing is removed
during the 5-minwash . There is no further release
of labeled peptide into the medium during a 15-
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The rate and extent of receptor loss are depend-
enton theconcentration ofFNLLPpresentduring
the preincubation. Down regulation is rapid . Most
of the receptor loss occurs during the first 5 min,
even before equilibrium binding is reached (Fig .
3). A plateau level of receptors is also rapidly
achieved (within 15 min even at 3 X 10-9 M) . The
rapidity of the down regulation caused us to miss
the phenomenon in our original experiments (38).
Down regulation is mediated by peptide binding
to the specific, saturable receptor . The dose re-
sponse correlates with the binding of FNLLP to
its receptor, with thehalf-maximal loss ofreceptors
occurring at aconcentration near theK dofbinding
(Fig . 4) . The analogue HNLLP, which does not
bind to the receptor, does not cause any receptor
loss . The competitive inhibitor CBZ-Phe-Met also
does not result in any down regulation . CBZ-Phe-
Met has been shown to compete for the peptide-
binding site without inducing any of the chemo-
tactic responses (21) . CBZ-Phe-Met does inhibit
FNLLP-induced down regulation.
The affinity of the receptors which remain after
down regulation was determined by Scatchard
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FIGURE 3 Rate of receptor loss at different peptide
concentrations . Cells were preincubated at 37°C with
(") 3 x 10-9 M, (O) 3 x 10-' M, and (A) 3 x 10-' M
unlabeled FNLLP for various times. At the end of this
incubation, the cells are washed for 5 min at 4°C and
then incubated at 4°C for 15 min with 2 X 10"8 M
[3H]FNLLP . The binding capacity is plotted as cpm
bound/ 10' cells as a function of preincubation time
with unlabeled FNLLP. (A) Cells preincubated without
peptide. Nonsaturable binding at this concentration of
[3H]FNLLP is -500 cpm.
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Down regulation dose response .The percent
saturable receptor loss as a result of incubation with
unlabeled peptide for 30 min at 37°C is plotted semilog-
arithmically as a function of peptide concentration. Re-
ceptor loss is calculated as a percent of the saturable
binding of2 x 10-8M [3H]FNLLP by cells preincubated
without peptide .
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FIGURE 5 Dose response of FNLLP binding before
and after down regulation. Left panel, cells were incu-
bated in the presence (") or absence (O) of l0' M
unlabeled FNLLP at 37°C for 30 minandwashed for 5
min at 4°C . Binding capacity was measured after incu-
bation with various concentrations of [3H]FNLLP for 15
min at 4°C . Right panel, data plotted according to the
method of Scatchard .
analysis . The K d of control cells without preincu-
bation in peptide is 2.3 X 10-8 M. The Kd of cells
preincubated in 10-' M FNLLP which reduced
the number of binding sites by 54% is 1.9 X 10-5
(Fig . 5). Both are within the range oferror of our
estimate for the Kd which is 2.2 ± 0.3 X 10-8M
(mean ± SD) . This supports the contention thatthe decrease in binding capacity is not because of
competition by unlabeled FNLLP. Competition
would alter the affinity constant rather than the
number of binding sites (15).
Down regulation also occurs at 4°C, although
to a lesser extent . Incubation with 10-'MFNLLP
results in a68% loss in receptors at 37°C compared
to 21% at 4°C (Fig . 6) . The plateau levelof recep-
tor concentration is still reached within 15 min .
Examination of the binding of tritiated FNLLP
indicates that there is an increase in irreversibly
cell-associated peptide with this same time-course.
At this temperature, the amount of irreversibly
cell-associated peptide is approximately equal to
the number of receptors lost . The number of irre-
versibly bound peptide molecules at 10' M
FNLLP is 1 .8 t 0.2 x 10' . The number of recep-
tors that are lost after down regulation at this
concentration and temperature is 1.9 x 104 .
Recoveryfrom Down Regulation
The recovery from down regulation also occurs
rapidly . After down regulation, cells were washed
at4°C andthen incubated at 37°C without peptide
for various periods of time and then tested for the
ability to bind tritiated peptide . Cells regain 80-
100% of initial binding capacity within 20 min
(Fig . 7) . Both down regulation and recovery are
independent of protein synthesis. The addition of
cycloheximide (1 pg/ml) which inhibits the incor-
y
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FIGURE 6
￿
Temperature dependence of down regula-
tion. Cells were incubated at 37°C (O) or 4°C (") for
various lengths of time with 10-' M unlabeled FNLLP .
After a 5-min wash at 4°C, 2 x 10-8M [3H]FNLLPwas
added for 15 min at 4°C . Binding capacity is plotted as
a function ofthe length of preincubation with unlabeled
FNLLP at each temperature . (A) Cells preincubated
without peptide .
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FIGURE 7
￿
Recovery ofreceptors afterdown regulation.
Cells were incubated for 20 min at 37°C with Hanks'
solution (A, O) or 10'M unlabeled FNLLP (A,") and
washed for 5 min at 4°C . The ability to bind 2x 10-eM
[3H]FNLLP was then tested immediately (To, Tzo) or
after incubation in Hanks' solution at 37°C for various
times . Cells incubated with 1 leg/ml cycloheximide were
subjected to the same protocol (O, ") .
poration of tritiated amino acids by 92% had no
effect .
Evidencefor FNLLP Uptake
As seen in Fig. 1, the amount ofpeptide bound
at 4°C reaches a plateau within 15 min . In con-
trast, at 37°C the binding does not reach a plateau
but continues to increase at a reduced rate . How-
ever, the increase is caused by irreversibly bound
peptide . The amount of reversibly bound peptide
does indeed reach a plateau at 37° as at 4°C. The
number of reversibly bound receptors at 3 x 10-e
M FNLLP is 2.45 ± 0.3 x 104 (Fig. 8) . This
corresponds well with the number of receptors
available for binding afterdown regulation at this
concentration, 2.58 ± 0.4 x 104 . This increase in
cell-associated peptide appears to be energy de-
pendent because it is inhibited by 2-deoxy-D-glu-
cose as well as by a temperature of 4°C . The
accumulation of irreversibly cell-associated pep-
tide decreasesby 74% when the cells areincubated
at 37°C with 0.5 mM 2-deoxy-D-glucose . Down
regulation at 37°C is not affected by the addition
of 2-deoxy-D-glucose .
The dose-response curve for the accumulation
of irreversibly cell-associated FNLLP at 37°C is
shown in Fig . 9. The dose-response curve reflects
the binding ofFNLLP to its receptor, suggesting
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FIGURE 8
￿
Reversibility of binding at 37°C . (") Cells
were incubated for various lengths of time at 37'C with
3 x 10-8M [3H]FNLLPand washed quickly (6 s) at the
end ofthe incubation . (O) After incubation for 5, 15,and
30 min, cells were washed at 4'C for various lengths of
time .
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FIGURE 9
￿
FNLLP uptake . (") FNLLP remaining cell
associated after a 30-min incubation at 37°C followed
by a5-min wash at 4'C as a function ofFNLLPconcen-
tration . The dotted line represents saturable uptake (to-
tal-nonsaturable) . Nonsaturable uptake is calculated
from the uptake of 10-3M [3H]FNLLP in the presence
of 10-5M unlabeled FNLLP . This data is not corrected
for peptide release .
that the uptake is receptor mediated . However,
uptake continues to increase at concentrations
above those that would saturate all of the recep-
tors . This is presumably because of pinocytic up-
take of increasing amounts ofFNLLP in the fluid
and nonspecifically associated with the cell sur-
face . The amount of nonsaturable uptake was
measured as the irreversible accumulation of 10_s
M [3H]FNLLP in the presence of 10-'M unlabeled
FNLLP . The nonsaturable uptake appears to be
linear, so the degree of nonsaturable uptake at
each concentration was calculated and subtracted
from total to give saturable uptake. The calculated
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,urve for saturable uptake (Fig . 9) is very similar
to that of FNLLP binding to the receptor. CBZ-
Phe-Met competition for uptake provides addi-
tional support for the hypothesis that this uptake
is receptor mediated .Theaddition of 10-°MCBZ-
Phe-Met decreases the rate of 10-8 M FNLLP
uptake by --70% (Fig . 10) . This correlates with the
degree of competition for receptor binding seen at
these concentrations of antagonist and peptide .A
study of peptide release indicates ^-20% of the
"irreversibly" associated counts are released into
the medium during a 30-min incubation at 37'C
in Hanks' solution.
PMNs have not been considered to be actively
pinocytic cells . Nevertheless, the addition of the
chemotactic peptide stimulates the uptake of triti-
ated sucrose from the medium, presumably
through apinocytosis mechanism . Theaddition of
10'MFNLLP increases the rate of fluid uptake,
as measured by the amount of 10-6M sucrose that
becomes irreversibly cell associated, from 1.7 to
6.6 nl/min per 10' cells (Fig . 11). This stimulation
of fluid uptake is not sufficient to account for the
uptake of FNLLP, which again suggests that the
y
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FIGURE 10 CBZ-PHE-MET competition for FNLLP
uptake . Accumulation ofirreversibly cell-associated 10-"
M [3H]FNLLP in the presence (") and absence (O) of
10-'M CBZ-PHE-MET.3,000
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FIGURE 11 Peptide stimulation of pinocytosis . Cells
were incubated for various lengths of time at 37°C with
10'M ['H]sucrose in the presence (") and absence (O)
of 10'M unlabeled FNLLP. At the end of the incuba-
tion, the cells were washed for 5 min at 4°C.
peptide uptake is receptor mediated . Stimulation
of sucrose uptake does notappear to be dependent
upon the concentration of FNLLP present . Con-
centrations ranging from 10-' to 10-9 M FNLLP
result in the same fourfold increase .
This peptide uptake could be caused by trans-
port or receptor-mediated internalization . If this
increase in irreversibly cell-associated counts does
represent receptor-mediated internalization, a
mechanism for resupplying receptors to the cell
surface would be required . At 10'MFNLLP, the
amount of nondissociable peptide accumulated
after 90 min at 37°C is equivalent to three times
the number of receptors initially present .
There is also some stimulation of pinocytosis
even at 4°C . The addition of 10-' M FNLLP
results in a rapid, transient increase in sucrose
uptake which lasts less than 5 min (Fig. 12) . Al-
though this uptake couldbe entirely separate from
the down regulation, it suggests that a pinocytic
mechanism is functional .
Many recent studies have shown that the binding
of ligands to their cell surface receptors modulates
the number of available receptors and, thus, the
sensitivity and responsiveness of a cell to that
ligand . A decrease in the concentration of acces-
sible receptors as a result of incubation with the
ligand hasbeen termeddown regulation . Receptor
down regulation has been demonstrated for a
number of hormones and neurotransmitters (4-6,
10-12), low density lipoprotein (2), and for the
chemotactic agent cyclic AMP in Dictyostelium
discoideum (15) .
Our data indicate that down regulation of the
chemotactic peptide receptor is a rapid response
ofPMNs to incubation withFNLLP. Several lines
of evidence support this as being a specific result
of FNLLP binding to its saturable receptor. Both
the rate and extent ofdown regulation areconcen-
tration dependent, and the dose response parallels
that of FNLLP binding. Receptor loss is not in-
duced by HNLLP, a nonchemotactic analogue of
FNLLP that does not bind to the receptor. The
antagonist CBZ-Phe-Met competes with FNLLP
for receptor binding but does not stimulate any of
the chemotactic responses, including down regu-
lation . However, CBZ-Phe-Met will inhibit
FNLLP-induced down regulation presumably be-
cause of competition for the receptor.
Down regulation is clearly temperature depend-
ent although it does occur at 4°C . Examination of
the binding at this temperature reveals a compo-
nent that is not readily dissociable . The amount of
irreversibly cell-associated peptide corresponds to
the number of receptors down regulated at 4°C .
The existence of an irreversible component of
binding and down regulation at this temperature
is quite surprising . It should be considered in
interpreting both Scatchard and kinetic binding
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FIGURE 12
￿
Stimulation ofpinocytosis at 4°C . (O) Cells
were incubated at 4°C with 10- ' M [3H]sucrose for
various periods of time. (") After 15 min at 4'C with
[''H]sucrose, 10-7 M unlabeled FNLLP was added for
various lengths of time ; arrowhead, addition of peptide .
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same Kd valueusing these two independent meth-
ods, both may overestimate the binding affinity
because each method assumes equilibrium (en-
tirely reversible) binding . The use of labeled plus
excess unlabeled peptide as a measure of nonsat-
urable binding is useful in many instancesbut also
may lead to erroneous estimates because the high
concentration of peptide present will induce down
regulation. Furthermore, there is a component of
nonsaturable bindingwhich is not reversible .Thus
we chose to study the reversal of binding through
dilution and washing rather than by competition
with excess unlabeled peptide .
Several mechanisms could cause the loss of
receptors . The binding of peptide could result in
a modification of the receptor that leads to much
higher affinity binding . A change in receptor af-
finity has been proposed to account for down
regulation in other systems (17, 28, 33, 35) . This
change could be because of a change in confor-
mation, some other modification such as methyl-
ation or phosphorylation, or association with an-
other membrane component . A second possibility
is that bound receptors are internalized by the cell.
Such a pinocytic mechanism has been established
where it has been possible to follow the receptors
directly (5, 8) . In other studies, ultrastructural data
indicate that receptor-mediated internalization of
ligands occurs via coated vesicles (2, 5, 10) . There
is some evidence for receptor-mediated internali-
zation in our system. We have shown that down
regulation is accompanied by a rapid stimulation
of [?H]sucrose uptake from the medium . Further-
more, Niedel et al . (19) have followed fluorescently
labeled chemotactic peptide and presented evi-
dence for its clustering and internalization .
At 37°C, the uptake of FNLLP and the stimu-
lated uptake of sucrose continue, even after the
receptor number has equilibrated . The dose-re-
sponse curve for peptideuptake indicates that it is
mediated both by a saturable receptor with ap-
proximately the same affinity as the chemotactic
receptor and by bulk pinocytosis uptake of
FNLLP in the external fluid . Receptor-mediated
uptake could be via active transport of peptide or
pinocytosis internalization of the receptor ligand
complex . IfFNLLP uptake is caused by receptor-
mediated pinocytosis, there must be a mechanism
for resupplying receptors to the cell surface be-
cause, after90min in 10-7MFNLLP, the amount
of peptide internalized exceeds the number of
receptors initially present by 300% . This would
710
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require replacement of all the receptors every 30
minfrom an internal pool or via receptor recycling
(9).Therelationship betweenthe irreversible bind-
ing of peptide, the loss of receptors that occurs
rapidly (down regulation), and the increasing ac-
cumulation of irreversibly bound peptide that oc-
curs after the receptors are at a steady-state level
requires further study .
It is well established that PMNs become deac-
tivated in response to chemotactic stimulation.
Deactivation is defined as a decrease in respon-
siveness to a chemotactic factor as a result of
previous exposure to the stimulus (20) . We have
recently shownthat PMNs adapt to the concentra-
tion of chemotactic peptide which is present but
remain sensitive to changes in concentration. Ad-
aptation is suggested bya number of biochemical
and morphological responses to chemotactic fac-
tors which are transient even though the chemo-
tactic factor continues to be present and the cells
continue to respond to changes in the concentra-
tion of the chemotactic factors. Receptor modu-
lation may be involved in one or both of these
processes .
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Note added in proof: While this manuscript was in press,
two studies appeared which also indicate receptor mod-
ulation in PMNs, Vitkausas et al ., Mol. Immunol. 17:
171-180, and Niedel et al ., J. Biol. Chem. 254:10700-
10706 .
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